Some orthopaedic patients might be at risk for enterococcal infections and might benefit from adapted perioperative prophylaxis.
The predominant infective organisms in orthopaedic surgery is Staphylococcus aureus [1] . 2 Accordingly, guidelines and experts recommend the use of 1 st and 2 nd generation 3 cephalosporins for perioperative prophylaxis [2] unless the patient is known to be colonized 4 with methicillin-resistant S. aureus (MRSA) and thus vancomycin is recommended [3] . 5
However, cephalosporins lack activity against enterococci [4, 5] . For abdominal surgery there is 6 ongoing controversy whether a subset of multimorbid patients might benefit from enlarged 7 antibiotic prophylaxis including enterococcal coverage [6] and the relationship between 8 cephalosporin use and enhanced E. faecalis bacteraemia incidence has been published [4] . The 9 literature is sparse regarding orthoapedic infections and enterococci. For example, a PubMed 10 search on 15 October 2016 with the MeSH terms "enterococci", "orthopaedic", and "surgery" 11 only identified 26 publications. Some authors think that the overall prevalence of enterococcal 12 surgical site infections [1] might rise in the future [5, 7] and have epidemiologically linked the 13 increased cephalosporin use in perioperative antibiotic prophylaxis to the increasing incidences 14 of enterococcal implant-infection [5] . 15
The objective of the current study was to investigate whether some orthopaedic patients / types 16 of procedures are at risk for enterococcal infection. Of note, we do not address prevention [1] , 17 pathophysiology [8] , therapy and outcomes of orthopaedic due to enterococci, for which a 18 broader literature is available [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . 19 20
Methods 21
We performed a single-centre, retrospective cohort study of adult patients operated at our 22 tertiary Orthopaedic Referral Centre at the University of Geneva Hospitals between January 23
2004 and December 2014. Our Orthopaedic Centre also manages all trauma-related infections 24 and soft-tissue infections requiring surgery (e.g. abscesses, septic bursitis, myositis, or 25 fasciitis). The proportion of MRSA among all clinical S. aureus isolates ranged between 15%
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2 and 25% during the study period [19] . Hospital-wide, the proportion of penicillin-resistance 27 was 1% for E. faecalis and 87% for E. faecium. We defined infection clinically as the presence 28 of intraoperative pus, together with other signs or symptoms (new onset of pain, fever, warmth,  29 redness, discharge), or radiographic signs of implant loosening or the presence of sequestrae. 30
The detailed definitions for prosthetic joint, nosocomial and diabetic foot infections stem from 31
the Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection [20] , 32
the Diabetic Foot Infection Guidelines of the Infectious Diseases Society of America [21] , and 33
the Center of Disease Control (CDC) definitions of healthcare-associated infections [2] . For 34 this study, we considered early-onset open fracture infections as community-acquired, since 35 they were usually acquired on the road [22] . To avoid data clustering, we included only the 36 first episode of the same infection and excluded recurrent episodes (and pediatric cases) from 37 further analysis, unless there would be improbable situation that the recurrent pathogen of the 38 infection would be an Enterocccous sp (as the new pathogen). The composite database was in 39 line with the local Ethical Committee requirements. 
Statistical analysis 56
Group comparisons were performed using the Pearson-χ 2 -test, Fisher-exact-test or the 57
Wilcoxon-ranksum-test, as appropriate. To adjust for case-mix, we performed an unmatched 58 logistic regression analysis (outcome enterococcal infection). Independent variables with a p 59 value ≤0.20 in univariate analysis were introduced stepwise into the multivariate analysis [25] . 60 P values ≤0.05 (two-tailed) were significant. We used STATA ™ software (9.0; Texas, USA). Enterococci were the primary pathogen in 28 cases according to quantitative interpretation of 90 the microbiology technician. These groups of co-pathogens were Staphylococcus aureus 91 (n=14; of which 2 due to MRSA), Gram-negatives (n=32; of which 15 non-fermenting rods, 92 including 8 cases with Pseudomonas spp), streptococci (n=3), skin commensals 93 (corynebacteria, micrococci, coagulase-negative staphylococci; n=13). We could not detect co-94 infection with propionibacteria or anaerobes. Throughout the entire study period, we failed to 95 detect an outbreak of enterococcal infections (more than two cases on a ward) in our service. sampling. In three cases, the antibiotic was stopped ("antibiotic-free window") seven days 111 before. This "antibiotic-free window" was one day, two days, three days, six days, and eight 112 days in the remaining six cases ( Table 1) and 2) albeit it did not reach significance in the multivariate results (Table 2) . 123 124
Non-antibiotic associations with enterococcal infection 125
The proportion of enterococci among all pathogens in diabetic foot infections was 7%. In 3) and polymicrobial infection (OR 6.0, 95%CI 3.9-9.4) were strong associations with 130 enterococci, while sex, age, and type of implant were not ( Table 2) . 131 132 Discussion 133
In this 11-year retrospective, single referral-centre cohort study, we addressed the question 134 which type of orthopaedic patients gets infected with enterococci. We found that enterococcal 135 infections were rare. They contributed only to 3.6% of all infections. The nosocomial or 136 monomicrobial parts were even smaller with corresponding total incidences of 0.7% and 0.7%, 137
respectively. With a proportion of 85%, we encountered enterococci mostly as co-pathogens in 138 polymicrobial and implant-related infections, and in the ulcerating diabetic foot. 139
140
In the literature, enterococci might accompany other pathogens 10% [16] , 18% [26] , 19% [7] , 141 22% [5] , 32% [18] , 33% [17] or 54% [29] of orthopaedic infections, but their overall incidence 142 is still less than four percents [9] [10] [11] 17, 27, 28] . Moreover, monomicrobial enterococcal bone 143 and joint infections are very often hematogenous [30] , stemming from a remote origin, e.g. 144 endocarditis [27, 28] or prostate [15] , whereas implant-free, native joint community-acquired 145 arthritis, septic bursitis or osteomyelitis due to enterococci are very seldom [7, 18, 31, 32] . In 146 contrast, enterococcal diabetic foot infections are a well-known clinical entity [21, 33, 34] . 147
148
In our analysis, enteroccocal infections were strongly related to prior cephalosporin exposure, 149 mostly administered as prophylaxis. Cephalosporins inherently lack anti-enterococcal activity 150 [4] . Our finding is in line with a large observational study involving more than thousand 151 patients from Denmark while total cephalosporin use increased three-fold in whole Denmark. In the same period, the 157 incidence of patients with enterococci in tissue samples increased steadily from 1.03% to 5.9%. 158
Moreover, the proportion of (penicillin-resistant) E. faecium increased from 7% in the first year period to 15% in the last 3-year. The association was impressive [5] . acnes [35] or skin commensals. In our orthopaedic database, there were zero enterococcal co-167 infections with P. acnes and only 13 with skin commensals. iii) Our perioperative antibiotic 168 regimens are in line with several Western European and US recommendations. However, these 169 might not be ubiquitous. For example, many centres facing major Clostridium difficile 170 problems might not use cephalosporins and might have switched to alternative prophylaxis 171 regimens such as teicoplanin, or flucloxacillin plus gentamicin with anti-enterococcal activity; 172 or many other combinations. Thus, our findings could be different in these settings. iv) We 173 summarized imipenem as an agent with anti-enterococcal activity. Like other institutions, we 174 cannot directly test enterococcal isolates for imipenem susceptibility [36, 37] 1.7 (1.1-2.6)  2.0 (1.2-3.3) -Prosthetic joint infection 1.6 (0.9-2.7) n.d. 2.3 (1.5-3.6)  1.9 (1.2-2 
Osteosynthesis (implant) infection

Foot infection
.9)
Polymicrobial infection 0.5 (3.0-10.0) 6.0 (3.9-9.4)
